BD AutoShield Duo™ pen needle

Keep safety injections short and simple

Carousel Image
Loading
tabs dropdown arrow
About

The BD AutoShield Duo™ pen needle is a safety pen needle that comes in a 5-mm size to facilitate safer insulin injections.1 Featuring patented automatic dual-protection shields on both ends of the needle, it helps prevent needlestick exposure and injury during injection and disposal. Conveniently, the BD AutoShield Duo™ pen needle is compatible with leading diabetes medication pens in the United States.

true

Features and Benefits

  • Needle concealment

     

    An outer shield conceals the 5-mm single-use needle, so patients do not need to see it or feel intimidated by it.

     

  • Reduced IM injection risk

     

    By delivering subcutaneous injections, the 5-mm pen needle helps reduce the risk of intramuscular (IM) injections that can increase the risk of hypoglycemia in patients, regardless of their body mass index (BMI).1–3

     

  • Large barrel

     

     

    The pen needle features a large barrel for easy handling and attachment.

     

     

  • Red indicator band

    After users finish performing the injection and lift the pen needle away from the skin, the pen's inner shield automatically deploys and locks. A red indicator band then confirms that the shield is locked and the needle has been used.

  • Reduced IM injection risk

    By delivering subcutaneous injections, the 5-mm pen needle helps reduce the risk of intramuscular (IM) injections that can increase the risk of hypoglycemia in patients, regardless of their body mass index (BMI).1–3

     

  • Thin wall technology

    Our needles retain their extremely fine external dimensions but with a wider inner diameter, improving insulin flow rate and requiring less force.4

     

  • OSHA compliance

    The pen needle helps meet the OSHA requirement to evaluate safer devices as they become available.5 It is the only safety pen needle that passively conceals the needle in the front and back after use, reducing nurse exposure to the needle.

  • Rigorous testing

    The pen needle is rigorously tested for fit, function and dose accuracy.

  • Single-handed injection technique

    Because the BD AutoShield Duo™ pen needle does not require a pinch-up technique, the risk of needlestick injury during injection may be reduced.

Related Product

Resources
FAQ

Insulin pens are the size and shape of a large marker. They carry insulin in a self-contained cartridge. Insulin pens are easy to use and growing in popularity.

Some people use insulin pens for all of their injections, while others carry them when they are on the go and rely on less expensive and more versatile insulin syringes when they need to do the following:

  • Mix different insulins.
  • Take an insulin that is not available in a pen.
  • Inject at home.

Insulin pens are used with pen needles that are sold separately. A new pen needle should be used for each injection.

Insulin pens are not sold or distributed by BD. They are manufactured and sold by three major insulin companies in the United States: Eli Lilly, Sanofi and Novo Nordisk. As a company, we manufacture and sell pen needles that are compatible with leading diabetes medication pens.

In recent years, pens have become popular for people living with diabetes. To provide continuity of care, some hospitals are now considering the use of insulin pens.

Insulin pens may contribute to cost savings. Pens contain 300 units of insulin, which is a good quantity for patients who are admitted for a two- to three-day hospital stay. By contrast, insulin vials contain 1,000 units of insulin; any excess insulin must be discarded after the patient is discharged.

In the United States, hospitals could not make this transition due to the lack of a safety-engineered pen needle. BD now offers a safety-engineered pen needle, the BD AutoShield Duo™ pen needle.

BD pen needles can be used with leading diabetes medication pens sold in the United States. They are tested in accordance with ISO standards for compatibility.

Yes. BD pen needles can be used with leading diabetes medication pens sold in the United States. They are tested in accordance with ISO standards for compatibility.

BD currently offers 4-mm x 32-G, 5-mm x 31-G, 8-mm x 31-G, and 12.7-mm x 29-G pen needles. Recommendations on insulin delivery published in Mayo Clinic Proceedings state the following:

"The shortest needles (currently, the 4-mm pen and 6-mm syringe needles)* are safe, effective and less painful and should be the first-line choice in all patient categories."1

Therefore, BD recommends that pen needle patients upgrade to the BD Nano™ 4mm pen needle.

In many cases, local communities establish disposal rules. So first, check with your town or trash removal company on what they recommend for the safe disposal of used insulin syringes. A good place to call may be your local health department. The following guidelines may be helpful:

  • Never throw loose pen needles into the trash. If you are disposing of your own pen needle, clip the needle with a needle-clipping device such as the BD Safe-Clip™ needle storage device, which you can order at your pharmacy.
  • Never handle someone else's pen needle unless a healthcare professional trains you in proper injection technique and disposal. If you inject someone else or dispose of their pen needle, use extreme caution to avoid needlesticks, which can transmit serious and even grave infections.
  • Never recap or destroy a needle that has been used by someone else. Immediately after the injection, place the used pen needle in a safe container.
  • Put the used pen needle into a BD home sharps container, or check with your local sanitation or health department regarding rules on properly disposing of used pen needles and sharps containers. Keep this container away from children. When the container is full, seal the lid securely and dispose of it properly.
  • Never dispose of used pen needles or other medical waste in recyclable trash.

BD pen needles with PentaPoint Comfort is a BD pen needle innovation that has a five-bevel needle tip. While other brands only provide three bevels, PentaPoint Comfort delivers five bevels that create a flatter, thinner surface designed to penetrate the skin with significantly greater ease and enable a more comfortable and easier injection.2

BD is always looking for ways to better address its customer's unmet needs. Since minimizing pain during injection is an area of great concern for patients, BD developed BD PentaPoint Comfort to provide a less painful and more comfortable injection experience. In a clinical trial, the five-bevel needle tip was perceived as less painful and preferred by patients following home use with their usual injections.2

Bevels are angled edges at the needle tip that create a sharp point and facilitate penetration into the skin. With an increased number of bevels, a pen needle can more easily enter the skin and thereby, increase comfort as well as reduce pain for patients. Standard pen needles have only three bevels.2 BD pen needles with PentaPoint Comfort technology are the first and only pen needles with five bevels for a more comfortable injection experience.

Currently, PentaPoint Comfort is only available on BD pen needles, not on BD insulin syringes.

BD offers PentaPoint Comfort only on 31-G and 32-G BD pen needles in 4-mm, 5-mm and 8-mm lengths.

BD pen needles with PentaPoint Comfort require 23% less force to be inserted. Because it requires less penetration force, the pen needle is designed to enter the body more easily and smoothly, and therefore, it provides a more comfortable and less painful injection experience.2

The BD AutoShield Duo™ pen needle is a safety-engineered pen needle incorporating BD needle technology, providing the following features:

With proper handling, the back end of the needle would not normally be touched.

The BD AutoShield Duo™ pen needle covers both ends of the needle, so needlephobia is reduced. The BD AutoShield Duo™ pen needle is the only dual-ended safety-engineered pen needle available in the 5-mm length.

Your facility can use BD products with confidence because BD is the leader in healthcare worker safety for the following reasons:

  • Pioneered safety products: BD introduced the world's first safety-engineered syringe.
  • Track record in multiple technologies: BD offers the most extensive array of safety-engineered injection products available.
  • Hospital leadership: More hospitals in the United States use BD insulin syringes than any other brand.
true

Notes and References

* Children from 2 to 6 years old, extremely lean adults or people with loose skin may need to use a pinch-up technique.

† Users must avoid placing their fingers on either end of the pen needle shields.

 
  1. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
  2. Frid A, Hirsch L, Gaspar R, et. al. New injection recommendations for patients with diabetes. Diabetes Metab. 2010;36 Suppl 2:S3-S18.
  3. Karges B, Boehm BO, Karges W. Early hypoglycemia after accidental intramuscular injection of insulin glargine. Diabet Med. 2005;22(10):1444-1445.
  4. Aronson R, Gibney MA, Oza K, Bérubé J, Kassler-Taub K, Hirsch L. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence and other patient ratings. Clin Ther. 2013;35(7):923-933.
  5. Occupational Safety and Health Administration. Bloodborne pathogens. 29 CFR §1910.1030. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051.

Request a demo or get in touch with our sales representative

Sales Form
Please fill out the form and a sales representive will get in touch with you.

Capability

Product Line

Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×